S.Biomedics Co., Ltd.

₩17,730As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:304360Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR 7.49%
Div yield —
ROE (39.31%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 1.45
PE TTM —
TSR TTM (24.71%)
Mkt cap ₩219.6B
ROIC (15.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩22,471
26.74%
(75.88%)
Hold 9|8|10|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
252.09
241.19
233.88
226.29
2.14%
(3.33%)
(6.60%)
(9.66%)
Revenue₩B
21.35
21.53
22.70
22.68
14.38%
11.89%
15.87%
12.36%
Peers (US$161.9M)
Cap (US$)
PE
145.8M
—
Capital
TTM
5Y
10Y
Leveragex
9.405
0.036
0.037
EBIT/Intx
1.691
2.531
2.500
Own earn%
54.91
(8.59)
(8.13)
Sh yield%
32.42
39.53
41.96
Owners
Insiders/Inst%
1.68
52.43
Short interest%
3.20
SBC / revenue%
4.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
4–9
$1 testx
—
Incr. ROIC%
22